Dec 24, 2019
Reversible Contraceptive Devices (General Surgery) - Global Market Analysis and Forecast Model
Oct 28, 2019
FDA Approves Medicines360's LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Six Years, the Longest Approved Duration of Use of Any Hormonal IUDs
Oct 21, 2019
Bayer Submits Supplemental New Drug Application to FDA for Intrauterine Device (IUD) Mirena® (levonorgestrel-releasing intrauterine system) 52 mg
Jul 02, 2019
The Future of the Intrauterine Devices (IUD) Market by Product, End-use and Region (2019-2024)
Jun 24, 2019
The global hysterometers market size at a CAGR of over 4% during the forecast period
Apr 30, 2019
GLOBAL INTRAUTERINE CONTRACEPTIVE DEVICES MARKET FORECAST 2019-2027
Oct 16, 2018
FDA Approves Medicines360's sNDA for LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg to Prevent Pregnancy for up to Five Years
Sep 06, 2018
Medicines360, Afaxys Partner to Expand Public Health Access to LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg
Aug 20, 2018
Medicines360 and Direct Relief Partner to Expand Access for U.S. Women
Aug 13, 2018
Global Intrauterine Devices Market Research Report 2018 - Forecast to 2023
Jul 20, 2018
Bayer to voluntarily discontinue U.S. sales of Essure at end of 2018 for business reasons
May 22, 2018
The global hormonal contraceptive market size is expected to reach USD 26.2 billion by 2025
May 07, 2018
Medicines360, WCG, and Population Services International Announce Launch of AVIBELA(TM) Hormonal Intrauterine System in Madagascar
Apr 09, 2018
Bayer Statement about Essure® Label Update
Apr 09, 2018
Hormonal Contraceptive Market Size Worth $26.2 Billion By 2025: Grand View Research, Inc.
Feb 22, 2018
FDA Acceptance of Medicines360's Filing for supplemental New Drug Application for LILETTA® (levonorgestrel-releasing intrauterine system) 52 mg
Jan 08, 2018
Global Contraceptive Devices Market Forecast to 2027
Nov 07, 2017
IUDs may have a surprising benefit: protection against cervical cancer